The use of mesenchymal stem cells in the complex treatment of kidney tuberculosis (experimental study)

AN Muraviov, TI Vinogradova, AN Remezova, BM Ariel… - Biomedicines, 2022 - mdpi.com
In recent years, the application of mesenchymal stem cells (MSCs) has been recognized as
a promising method for treatment of different diseases associated with inflammation and …

Rifampicin impairs adipogenesis by suppressing NRF2-ARE activity in mice fed a high-fat diet

T Gao, M Lai, X Zhu, S Ren, Y Yin, Z Wang, Z Liu… - Toxicology and Applied …, 2021 - Elsevier
Prolonged treatment with rifampicin (RFP), a first-line antibacterial agent used in the
treatment of drug-sensitive tuberculosis, may cause various side effects, including metabolic …

Nanoengineering/technology for tissue engineering and organ printing

M Raguraman, M Rajan - Emerging nanotechnologies for medical …, 2023 - Elsevier
In this modern era, tissue engineering is an extremely rapid emergent area in the scientific
field. The damaged organs, cells, or tissues can be replaced or repaired using …

Ultrasound-guided transplantation of mesenchymal stem cells improves adriamycin nephropathy in rats through the RIPK3/MLKL and TLR-4/NF-κB signaling

C Xia, L Shao, Y Ma, X Wang, Y Zhang… - Stem Cells and …, 2021 - liebertpub.com
Bone marrow stromal cell (BMSC) treatment has been shown to be beneficial for Adriamycin
nephropathy (ADR). However, the low transplantation rate is still the key factor that affects …

Nephroprotective Effect of Mesenchymal Stem Cell‐Based Therapy of Kidney Disease Induced by Toxicants

S Lin, W Lin, C Liao, T Zhou - Stem Cells International, 2020 - Wiley Online Library
Background. Renal damage caused by drug toxicity is becoming increasingly common in
the clinic. Preventing and treating kidney damage caused by drug toxicity are essential to …

Anti-tuberculosis drug-induced oxidative stress in kidneys: Role of brahmi as an antioxidant supplement

SE Prince, SJ Martin, BU Lavinya… - Pharmacognosy …, 2019 - phcog.com
Purpose: Nephrotoxicity is a known, but rare complication of anti-tuberculosis (TB) therapy
and is known to be due to induction of oxidative stress and immune reaction to the drugs. In …

[PDF][PDF] The Use of Mesenchymal Stem Cells in the Complex Treatment of Kidney Tuberculosis (Experimental Study). Biomedicines 2022, 10, 3062

AN Muraviov, TI Vinogradova, AN Remezova, BM Ariel… - 2022 - academia.edu
In recent years, the application of mesenchymal stem cells (MSCs) has been recognized as
a promising method for treatment of different diseases associated with inflammation and …

Protective action of ultrasound-guided intraparenchymal transplantation of BMSCs in adriamycin nephropathy rats through the ripk3/mlkl and nlrp3 pathways

C Xia, L Shao, Y Ma, X Wang, Y Zhang, C Shi, J Li… - Acta …, 2021 - Elsevier
Background Bone marrow stromal cells (BMSCs) are an effective new strategy for the
treatment of kidney diseases. At present, noninvasive and efficient transplantation …

[PDF][PDF] Beetroot Improves the Therapeutic Efficacy of Bone Marrow-Derived Mesenchymal Stem Cells in Preventing Cisplatin Induced Nephrotoxicity in Male Rats

WA Morsy, SM Kadry, MT Hassen, BA Abd El-Motelp - 2022 - biointerfaceresearch.com
Nephrotoxicity is the most prevalent side effect of the anticancer drug cisplatin (Cis). This
study aimed to assess the influence of beetroot (Br) or/and BM-MSCs on cisplatin-induced …

[HTML][HTML] Мезенхимные стволовые клетки в терапии туберкулеза

АН Ремезова, АА Горелова, АН Муравьев… - Consilium …, 2021 - cyberleninka.ru
Туберкулез (ТБ), вызываемый облигатным внутриклеточным микроорганизмом
Mycobacterium tuberculosis,-одно из древнейших известных инфекционных …